GlassScriptPhysician profile
Arvind Rengarajan
NPI 1427430057
$53,427.56
in general payments reported to CMS, 2019-2025
12 companies · $51K in 2025
The $51K reported for 2025 was more than what 97% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2022: $350 · 2023: $1,804 · 2024: $489 · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Food and Beverage: $2,193 · Travel and Lodging: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Food and Beverage | $2,192.61 |
| Travel and Lodging | $739.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $51,144.26 | 2022-2025 | General - Therapies, Resolution Clip, Axios |
| Ovesco Endoscopy USA, INC. | $739.78 | 2023 | |
| Medtronic, INC. | $439.57 | 2023-2025 | Gi Genius, Prodigi, Beacon |
| Olympus America INC. | $326.71 | 2024-2025 | Gastrointestinal Videoscope, Evis Exera III Colonovideoscope, Evis Exera III Video System Center |
| Erbe USA INC | $140.17 | 2023 | Erbe Vio3 |
| Conmed Corporation | $127.66 | 2024 | Conmed Hemostasis, Conmed Biliary |
| Covidien LP | $124.15 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.78 | 2023 | Trulance |
| Intercept Pharmaceuticals, INC. | $117.14 | 2023 | Ocaliva |
| Steris Corporation | $92.23 | 2025 | |
| Janssen Biotech, INC. | $32.57 | 2022 | |
| Cook Medical LLC | $20.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Rengarajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.